Editors Note: A recording of this conversation is embedded below.
Every week, STAT+ subscribers get access to exclusive conversations with biotech, pharma, and health tech leaders. This week, STAT news editor Megan Thielking will be joined by Casey Ross, national technology correspondent at STAT. They will discuss his recent investigation on the FDA’s regulation of artificial intelligence, and of course be taking your questions live.
Sponsored By
Featured speakers:
- Casey Ross, national technology correspondent, STAT
- Megan Thielking, news editor, STAT (moderator)
- Sponsor Introduction: Scott Schliebner, senior vice president, Center for Rare Diseases, PRA Health Sciences
About the Author Reprints
